Researchers tested experimental PCAI compounds against pancreatic cancer cells carrying KRAS mutations. One leading compound ...
Our cells rely on tightly regulated signaling pathways to control when they grow, divide and survive. When these regulatory ...
Researchers have uncovered a previously unrecognized pathway linking lung tumor genetics, diet, and the nervous system that drives cancer-associated cachexia, according to a new study in mice.
Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.
Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, ...
18hon MSN
Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic target
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic ...
Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.
In cancer research, one person's junk is increasingly becoming another person's treasure. Scientists have uncovered new ...
Signal transduction The cellular process that converts a signal, such as a hormone, growth factor, neurotransmitter, cytokine, mechanical force, or environmental cue, into biochemical changes inside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results